ES2428387T3 - Prostamidas donadoras de óxido nítrico - Google Patents

Prostamidas donadoras de óxido nítrico Download PDF

Info

Publication number
ES2428387T3
ES2428387T3 ES09742454T ES09742454T ES2428387T3 ES 2428387 T3 ES2428387 T3 ES 2428387T3 ES 09742454 T ES09742454 T ES 09742454T ES 09742454 T ES09742454 T ES 09742454T ES 2428387 T3 ES2428387 T3 ES 2428387T3
Authority
ES
Spain
Prior art keywords
ono2
independently selected
alkynyl
cycloalkoxy
alkoxyalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES09742454T
Other languages
English (en)
Spanish (es)
Inventor
Francesca Benedini
Stefano Biondi
Valerio Chiroli
Wesley Kwan Mung Chong
Liming Dong
Achim Hans-Pter Krauss
Fabio Nicoli
Ganesh Prasanna
William Francois Vernier
Yi Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nicox SA
Original Assignee
Nicox SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicox SA filed Critical Nicox SA
Application granted granted Critical
Publication of ES2428387T3 publication Critical patent/ES2428387T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/06Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ES09742454T 2008-05-09 2009-05-11 Prostamidas donadoras de óxido nítrico Active ES2428387T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5208408P 2008-05-09 2008-05-09
US52084P 2008-05-09
US13933308P 2008-12-19 2008-12-19
US139333P 2008-12-19
PCT/IB2009/005594 WO2009136281A1 (en) 2008-05-09 2009-05-11 Nitric oxide donating prostamides

Publications (1)

Publication Number Publication Date
ES2428387T3 true ES2428387T3 (es) 2013-11-07

Family

ID=41020929

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09742454T Active ES2428387T3 (es) 2008-05-09 2009-05-11 Prostamidas donadoras de óxido nítrico

Country Status (8)

Country Link
US (1) US8101658B2 (OSRAM)
EP (1) EP2274279B1 (OSRAM)
JP (1) JP5401540B2 (OSRAM)
CN (1) CN102099330B (OSRAM)
AR (1) AR076731A1 (OSRAM)
CA (1) CA2723704C (OSRAM)
ES (1) ES2428387T3 (OSRAM)
WO (1) WO2009136281A1 (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011005505A2 (en) * 2009-06-22 2011-01-13 Johnson Matthey Public Limited Company Method for the purification of prostaglandins
AU2012217922B2 (en) * 2011-02-14 2017-05-04 Allergan, Inc. Ester derivatives of bimatoprost compositions and methods
ES2690398T3 (es) 2012-03-07 2018-11-20 Advanced Inhalation Therapies (Ait) Ltd. Inhalación de óxido nítrico para el tratamiento de enfermedades respiratorias
ES2609810T3 (es) 2012-05-31 2017-04-24 Theravance Biopharma R&D Ip, Llc Inhibidores de neprilisina donadores de óxido nítrico
US10280138B2 (en) 2015-03-31 2019-05-07 Nicox S.A. Nitric oxide donating derivatives of fluprostenol
US10047047B2 (en) 2015-03-31 2018-08-14 Nicox S.A. Nitric oxide donating derivatives of latanoprost free acid
EP3088388A1 (en) 2015-04-30 2016-11-02 NicOx S.A. Nitric oxide donating derivatives of prostaglandins
US20180243526A1 (en) 2015-09-09 2018-08-30 Advanced Inhalation Therapies (AIT), Ltd. Nitric oxide inhalation therapy for infants with bronchiolitis
JP7055802B2 (ja) 2016-11-08 2022-04-18 ボシュ・アンド・ロム・インコーポレイテッド 正常眼圧緑内障を処置するための一酸化窒素放出プロスタグランジン誘導体
ES2836118T3 (es) 2018-02-21 2021-06-24 Nicox Sa Procedimiento para la preparación de un análogo de prostaglandina donante de óxido nítrico
RU2718744C2 (ru) * 2018-05-17 2020-04-14 Общество с ограниченной ответственностью "Гурус БиоФарм" Производные простагландина F2альфа для снижения внутриглазного давления
PT3593788T (pt) * 2018-07-12 2021-01-21 Nicox Sa Composições oftalmicas que contêm uma prostamida que liberta de óxido nítrico
ES2964005T3 (es) 2019-08-05 2024-04-03 Nicox Sa Procedimiento de preparación de un análogo de prostaglandina donador de óxido nítrico
PL4288413T3 (pl) 2021-02-03 2025-04-28 Nicox S.A. Sposób wytwarzania analogu prostaglandyny będącego donorem tlenku azotu
EP4404936A1 (en) 2021-09-20 2024-07-31 Nicox SA Nitric oxide releasing prostamide as neuroprotective agent
CN113943266A (zh) * 2021-11-18 2022-01-18 广州楷石医药有限公司 一种氧化氮供体型贝前列素类衍生物及其药物组合物和用途
EP4410294A3 (en) 2022-07-07 2024-11-06 Nicox S.A. Industrial process for the preparation of hexanoic acid, 6(nitrooxy)-,(1s,2e)-3-[(1r,2r,3s,5r)-2-[(2z)-7-(ethylamino)-7-oxo-2-hepten-1-yl]3,5-dihydroxycyclopentyl]-1-(2-phenyl ethyl)-2-propen-1-yl ester and high pure product
CN115677549A (zh) * 2022-10-27 2023-02-03 神隆医药(常熟)有限公司 一种贝美前列素手性异构体的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352708A (en) * 1992-09-21 1994-10-04 Allergan, Inc. Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
US6395787B1 (en) * 2000-02-08 2002-05-28 Allergan Sales, Inc. Ocular hypotensive lipids
TWI298257B (en) * 2001-05-31 2008-07-01 Allergan Inc Hypotensive lipid and timolol compositions and methods of using same
EP1336602A1 (en) * 2002-02-13 2003-08-20 Giovanni Scaramuzzino Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases
HUE025127T2 (en) * 2002-03-01 2016-01-28 Allergan Inc Production of prostamides
KR100854838B1 (ko) * 2004-01-05 2008-08-29 니콕스 에스. 에이. 프로스타글란딘 나이트로옥시 유도체
WO2007000641A2 (en) 2005-06-29 2007-01-04 Pfizer Inc. Prostaglandin derivatives
US20070015838A1 (en) * 2005-07-14 2007-01-18 Allergan, Inc. Cyclopentane n-lower alkyl heptenamide-5-cis-2-(3alpha-hydroxy-5-phenylpentyl)-3, 5-dihydroxy, [1alpha, 2beta, 3alpha, 5alpha] compounds as agents for lowering intraocular pressure

Also Published As

Publication number Publication date
WO2009136281A1 (en) 2009-11-12
EP2274279B1 (en) 2013-07-31
CA2723704A1 (en) 2009-11-12
US20110092590A1 (en) 2011-04-21
CN102099330A (zh) 2011-06-15
EP2274279A1 (en) 2011-01-19
CN102099330B (zh) 2014-04-30
AR076731A1 (es) 2011-07-06
US8101658B2 (en) 2012-01-24
HK1160835A1 (en) 2012-08-17
JP2011519910A (ja) 2011-07-14
JP5401540B2 (ja) 2014-01-29
CA2723704C (en) 2017-08-22

Similar Documents

Publication Publication Date Title
ES2428387T3 (es) Prostamidas donadoras de óxido nítrico
US12503475B2 (en) Bicyclic-heterocycle derivatives and their uses as orexin-2 receptor agonists
TWI475019B (zh) C型肝炎病毒抑制劑
CN102378762B (zh) 丙型肝炎病毒抑制剂
CA2975605C (en) 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as hdac inhibitors
ES2566800T3 (es) Nitrooxiderivados de prostaglandinas
CA3103711A1 (en) Spirocyclic indane analogues as il-17 modulators
JP2020523418A (ja) Il−17調節剤としてのスピロ環インドリン
KR101982912B1 (ko) 융합된 헤테로사이클릭 화합물, 이의 제조 방법, 약학적 조성물, 및 그 용도
CA3110767A1 (en) Benzimidazolone derivatives, and analogues thereof, as il-17 modulators
CN114685488A (zh) 作为sos1抑制剂的化合物及其应用
JP2024525044A (ja) Il-17モジュレータとしてのイミダゾトリアジン誘導体
WO2022128584A1 (en) Imidazopyridazine derivatives as il-17 modulators
WO2021170631A1 (en) Difluorocyclohexyl derivatives as il-17 modulators
WO2021204800A1 (en) Difluorocyclohexyl derivatives as il-17 modulators
WO2021170627A1 (en) Difluorocyclohexyl derivatives as il-17 modulators
EP4132650A1 (en) Difluorocyclohexyl derivatives as il-17 modulators
WO2019205979A1 (zh) 非天然氨基酸类衍生物、包含其的药物组合物及其制备方法和用途
EP0518672A2 (en) Cyclic renin inhibitors
TW201416363A (zh) C型肝炎病毒抑制劑
EP0518676A2 (en) Cyclic renin inhibitors
CA3259558A1 (en) COMPOUNDS FOR THE TREATMENT OF CORONAVIRUS INFECTION
HK1160835B (en) Nitric oxide donating prostamides
CN116440127A (zh) 一种多肽衍生物及其抗病毒用途
EP0432974A1 (en) Cyclic renin inhibitors